While tirzepatide does not directly cause specific micronutrient deficiencies through its mechanism of action, the secondary effects on eating patterns and gastrointestinal function warrant attention to nutritional adequacy
Almost 20% of the identified patients who initiated GLP1-RA stopped treatment within the first 12 months, the majority due to undesired side effects or a lack of effect
Anecdotal evidence suggests that GLP-1 RAs may be beneficial in IBD treatment
The glucagon receptor activation increases energy expenditure and promotes the breakdown of fat stores, particularly visceral fat that accumulates around organs
Challenge of Corneal Ulcer Healing: A Novel Conceptual Framework, the "Triad" of Corneal Ulcer Healing/Corneal Neovascularization/Intraocular Pressure, and Avascular Tendon Healing, for Evaluation of Corneal Ulcer Therapy, Therapy of Neovascularization, Glaucoma Therapy, and Pentadecapeptide BPC 157 Efficacy